New therapies in Paget's disease of bone.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001862:Bone Resorption / Q000187:drug effects; D002116:Calcitonin / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D006961:Hyperparathyroidism / Q000139:chemically induced; D006996:Hypocalcemia / Q000139:chemically induced / Q000150:complications; D007275:Injections, Intravenous; D008722:Methods; D063065:Organophosphonates / Q000008:administration & dosage*; D010001:Osteitis Deformans / Q000188:drug therapy*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D063065:Organophosphonates; D002116:Calcitonin; D006909:Hydroxyproline; D002118:Calcium